Healthcare Trust Reports Strong Q4 and Full-Year 2023 Performance

Healthcare Trust, Inc. (HTI) has reported its Q4 and full-year 2023 performance, showcasing significant improvements across various metrics compared to the previous period.

The company's high-quality portfolio, consisting of 204 properties with 76% in Medical Office Buildings (MOB) and 24% in Senior Housing Operating Properties (SHOP), demonstrated strong leasing momentum in the MOB portfolio. The MOB portfolio occupancy increased to 91.1% from 90.6% in Q4’23, driven by proactive leasing activities and 13 lease renewals totaling over 71,000 SF at a Lease Renewal Rental Spread of 11.1%.

HTI's diligent acquisition program resulted in the acquisition of seven properties in 2023, totaling $35.0 million at an average going-in Cap Rate of 6.8%, with subsequent acquisitions in 2024 totaling $12.6 million at a going-in Cap Rate of 7.6%.

The company's resilient performance is evident in the year-over-year improvements, with MOB portfolio NOI increasing by 2.1% to $97.5 million in 2023, and SHOP portfolio Adjusted NOI improving by 36.6% to $30.6 million in 2023.

HTI's portfolio is geographically diversified across 33 states, with a focus on deploying capital into high-quality MOB and SHOP assets throughout the United States.

The company's debt capitalization metrics as of Q4’23 indicate a balanced capital structure, with a focus on promoting financial flexibility and acquisition capacity by maintaining conservative net leverage of 43.7%.

As a result of these announcements, the company's shares have moved -2.5% on the market, and are now trading at a price of $15.37. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.